C. sinensis ablates allograft vasculopathy when used as an adjuvant therapy with cyclosporin A

Transplant Immunology

Volumn 19, Issue 3-4, 2008, Pages 159-166

  Jordan, J L ^a   Hirsch, G M ^b   Lee, T D G ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Acute rejection; Allograft vasculopathy; CD8+ T cells; Cordyceps sinensis; Cyclosporine; Transplantation

Indexed keywords

CALCINEURIN INHIBITOR; CORDYCEPS SINENSIS EXTRACT; CYCLOSPORIN A; EVEROLIMUS; FINGOLIMOD; GAMMA INTERFERON; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ACUTE GRAFT REJECTION; ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA GRAFT; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CD8+ T LYMPHOCYTE; CHINESE MEDICINE; CHRONIC GRAFT REJECTION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CORDYCEPS; CORDYCEPS SINENSIS; CYTOKINE PRODUCTION; GRAFT FAILURE; HEART GRAFT; HEART TRANSPLANTATION; HETEROTOPIC TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; MALE; MIXED LYMPHOCYTE REACTION; MONOTHERAPY; MOUSE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE ACTIVATION;

ADMINISTRATION, ORAL; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; COMBINED MODALITY THERAPY; CORDYCEPS; CYCLOSPORINE; DRUG SYNERGISM; GRAFT OCCLUSION, VASCULAR; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MEDICINE, CHINESE TRADITIONAL; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; RATS; RATS, INBRED LEW; TRANSPLANTATION, HOMOLOGOUS;

EID: 48149100743     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2008.05.010     Document Type: Article

References (47)

1. Agathos S.N., Madhosingh C., Marshall J.W., and Lee J. The fungal production of cyclosporine. Ann N Y Acad Sci 506 (1987) 657-662
2. Brinkmann V. FTY720: mechanism of action and potential benefit in organ transplantation. Yonsei Med J 45 (2004) 991-997
3. Baumruker T., Billich A., and Brinkmann V. FTY720, an immunomodulatory sphingolipid mimetic: translation of a novel mechanism into clinical benefit in multiple sclerosis. Expert Opin Investig Drugs 16 (2007) 283-289
4. Zhang Z., and Xia S.S. Cordyceps sinensis-I as an immunosuppressant in heterotopic heart allograft model in rats. J Tongji Medical University 10 2 (1990) 100-103
5. Hosenpud J.D., Bennett L.E., Keck B.M., Boucek M.M., and Novick R.J. The Registry of the International Society for Heart and Lung Transplantation: eighteenth Official Report-2001. J Heart Lung Transplant 20 (2001) 805-815
6. Hertz M.I., Taylor D.O., Trulock E.P., et al. The Registry of the International Society for Heart and Lung Transplantation: nineteenth Official Report-2002. J Heart Lung Transplant 21 (2002) 950-970
7. Ramzy D., Rao V., Brahm J., Miriuka S., Delgado D., and Ross H.J. Cardiac allograft vasculopathy: a review. Can J Surg 48 (2005) 319-327
8. Mitchell R.N., and Libby P. Vascular remodeling in transplant vasculopathy. Circ Res 100 (2007) 967-978
9. Pethig K., Heublein B., Wahlers T., Dannenberg O., Oppelt P., and Haverich A. Mycophenolate mofetil for secondary prevention of cardiac allograft vasculopathy: influence on inflammation and progression of intimal hyperplasia. J Heart Lung Transplant 23 (2004) 61-66
10. Schwarze M.L., Houser S.L., Muniappan A., et al. Effects of mycophenolate mofetil on cardiac allograft survival and cardiac allograft vasculopathy in miniature swine. Ann Thorac Surg 80 (2005) 1787-1793
11. Kaczmarek I., Ertl B., Schmauss D., et al. Preventing cardiac allograft vasculopathy: long-term beneficial effects of mycophenolate mofetil. J Heart Lung Transplant 25 (2006) 550-556
12. Libby P., and Pober J.S. Chronic rejection. Immunity 14 (2001) 387-397
13. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
14. Vessie E.L., Hirsch G.M., and Lee T.D. Aortic allograft vasculopathy is mediated by CD8(+) T cells in Cyclosporin A immunosuppressed mice. Transpl Immunol 15 (2005) 35-44
15. Nejat S., Zaki A., and Hirsch G.M. CD8+ T cells mediate aortic allograft vasculopathy under conditions of calcineurin immunosuppression: role of IFN-γ and CTL mediators. Transplant Immunol 19 2 (2008) 103-111
16. Skaro A.I., Liwski R.S., Zhou J., et al. CD8+ T cells mediate aortic allograft vasculopathy by direct killing and an interferon-gamma-dependent indirect pathway. Cardiovasc Res 65 (2005) 283-291
17. Zhou J., Carr R., Liwski R.S., Stadnyk A., and Lee T.D.G. Graft prolongation by oral exposure to alloantigen: Generation of intragraft CD8+ T regulatory cells. J Immunol 167 (2001) 107-113
18. Jordan J., Sullivan A., and Lee T.D.G. Immune activation by a sterile aqueous extract of C. sinensis: Mechanism of action. Immunopharmacol Immunotoxicol 30 (2008) 53-70
19. Koulack J., McAlister V.C., Giacomantonio C.A., Bitter-Suermann H., MacDonald A.S., and Lee T.D. Development of a mouse aortic transplant model of chronic rejection. Microsurgery 16 (1995) 110-113
20. Aneja R., Hake P.W., Burroughs T.J., Denenberg A.G., Wong H.R., and Zingarelli B. Epigallocatechin, a green tea polyphenol, attenuates myocardial ischemia reperfusion injury in rats. Mol Med 10 (2004) 55-62
21. Zhu X.Y., and Yu H.Y. Immunosuppressive effect of cultured Cordyceps sinensis on cellular immune response. Zhong Xi Yi Jie He Za Zhi 10 8 (1990) 485-487 454. ABSTRACT IN ENGLISH, ARTICLE IN CHINESE
22. Sun M., Yang Y.R., Lu Y.P., Gao R., Wang L., Wang J., and Tang K. Clinical study on application of bailing capsule after renal transplantation. Zhongguo Zhong Xi Yi Jie He Za Zhi 24 9 (2004) 808-810 ABSTRACT IN ENGLISH, ARTICLE IN CHINESE
23. Skaro A.I., Liwski R.S., O'Neill J., et al. Impairment of recipient cytolytic activity attenuates allograft vasculopathy. Transpl Immunol 14 (2005) 27-35
24. Krieger N.R., Yin D.P., and Fathman C.G. CD4+ but not CD8+ cells are essential for allorejection. J Exp Med 184 (1996) 2013-2018
25. Pietra B.A., Wiseman A., Bolwerk A., Rizeq M., and Gill R.G. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II. J Clin Invest 106 (2000) 1003-1010
26. Shizuru J.A., Seydel K.B., Flavin T.F., et al. Induction of donor-specific unresponsiveness to cardiac allografts in rats by pretransplant anti-CD4 monoclonal antibody therapy. Transplantation 50 (1990) 366-373
27. Onodera K., Lehmann M., Akalin E., Volk H.D., Sayegh M.H., and Kupiec-Weglinski J.W. Induction of "infectious" tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients. J Immunol 157 (1996) 1944-1950
28. Pearson T.C., Hamano K., Morris P.J., and Wood K.J. Anti-CD4 monoclonal antibody-induced allograft survival is associated with a defect in interleukin-2-dependent T-cell activation. Transplant Proc 25 (1993) 786-787
29. Pearson T.C., Darby C.R., and Wood K.J. Successful secondary heterotopic cardiac transplantation in the mouse. Transplantation 53 (1992) 701-703
30. Orosz C.G., Wakely E., Bergese S.D., et al. Prevention of murine cardiac allograft rejection with gallium nitrate. Comparison with anti-CD4 monoclonal antibody. Transplantation 61 (1996) 783-791
31. Gelman A.E., Okazaki M., Lai J., et al. CD4+ T lymphocytes are not necessary for the acute rejection of vascularized mouse lung transplants. J Immunol 180 (2008) 4754-4762
32. Lunsford K.E., Gao D., Eiring A.M., Wang Y., Frankel W.L., and Bumgardner G.L. Evidence for tissue-directed immune responses: analysis of CD4- and CD8-dependent alloimmunity. Transplantation 78 (2004) 1125-1133
33. Seydel K., Shizuru J., Grossman D., Wu A., Alters S., and Fathman C.G. Anti-CD8 abrogates effect of anti-CD4-mediated islet allograft survival in rat model. Diabetes 40 (1991) 1430-1434
34. Tang J.L., Subbotin V.M., Antonysamy M.A., Troutt A.B., Rao A.S., and Thomson A.W. Interleukin-17 antagonism inhibits acute but not chronic vascular rejection. Transplantation 72 2 (2001) 348-350
35. van Kuik J., de Koning E., van Wichen D.F., van Oosterhout M.F.M., Gmelig-Meyling F.H.J., de Jonge N., and de Weger R.A. 148 the IL-23/IL-17 axis in human cardiac allograft vasculopathy. J Heart and Lung Transplantation 26 2S (2007) 113
36. Aziz S., McDonald T.O., and Gohra H. Transplant arterial vasculopathy: evidence for a dual pattern of endothelial injury and the source of smooth muscle cells in lesions of intimal hyperplasia. J Heart Lung Transplant 14 (1995) S123-136
37. Sirak J., Orosz C.G., Wakely E., and VanBuskirk A.M. Alloreactive delayed-type hypersensitivity in graft recipients: complexity of responses and divergence from acute rejection. Transplantation 63 (1997) 1300-1307
38. Yun J.J., Fischbein M.P., Laks H., et al. Early and late chemokine production correlates with cellular recruitment in cardiac allograft vasculopathy. Transplantation 69 (2000) 2515-2524
39. Schober A., and Zernecke A. Chemokines in vascular remodeling. Thromb Haemost 97 (2007) 730-737
40. Russell M.E., Wallace A.F., Hancock W.W., et al. Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection. Transplantation 59 (1995) 572-578
41. Nagano H., Libby P., Taylor M.K., et al. Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma. Am J Pathol 152 (1998) 1187-1197
42. Mazanet M.M., Neote K., and Hughes C.C. Expression of IFN-inducible T cell alpha chemoattractant by human endothelial cells is cyclosporin A-resistant and promotes T cell adhesion: implications for cyclosporin A-resistant immune inflammation. J Immunol 164 (2000) 5383-5388
43. Raisky O., Spriewald B.M., Morrison K.J., et al. CD8(+) T cells induce graft vascular occlusion in a CD40 knockout donor/recipient combination. J Heart Lung Transplant 22 (2003) 177-183
44. Zhao D.X., Hu Y., Miller G.G., Luster A.D., Mitchell R.N., and Libby P. Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection. J Immunol 169 (2002) 1556-1560
45. Yi T., Cuchara L., Wang Y., et al. Human allograft arterial injury is ameliorated by sirolimus and cyclosporine and correlates with suppression of interferon-gamma. Transplantation 81 (2006) 559-566
46. Russell M.E., Räisänen-Sokolowski A., Mottram P., and Glysing-Jensen T. Knockout models of chronic cardiac rejection and graft arteriosclerosis: intimal thickening develops independent of Th1 and Th2 cytokines. Transplant Proc 29 (1997) 2531-2532
47. Zhao X., and Li L. Cordyceps sinensis in protection of the kidney from cyclosporine A nephrotoxicity. Zhonghua Yi Xue Za Zhi 73 (1993) 410-412 447. ABSTRACT IN ENGLISH, ARTICLE IN CHINESE